Cancer Immunotherapy
  • Featured content
    In this downloadable slideset, Margaret Callahan, MD, PhD; Shirish Gadgeel, MD; Ryan T. Merrell, MD; Bradley J. Monk, MD, FACS, FACOG; and Joyce O’Shaughnessy, MD, review important clinical presentations across multiple cancers from the 2016 oncology meeting in Copenhagen.
    Date Posted: 12/12/2016
  • Featured content
    In this CME-certified module, Geoffrey T. Gibney, MD, discusses promising research showing benefit to IDO inhibition approaches in early-phase studies in melanoma, lung cancer, and other cancers.
  • Featured content
    In this downloadable slideset, Osama E. Rahma, MD, provides an overview of immunotherapy in cancer, including tumor immunology and evolution of immune checkpoint inhibitors in solid tumors, from a satellite symposium at the 2016 American Association for the Study of Liver Diseases Annual Meeting.
    Date Posted: 11/11/2016
  • Featured content
    In this downloadable slideset, Osama E. Rahma, MD, provides an overview of immunotherapy in cancer, including tumor immunology and evolution of immune checkpoint inhibitors in solid tumors, from a satellite symposium at the 2016 American Association for the Study of Liver Diseases Annual Meeting.
    Date Posted: 11/11/2016
  • Featured content
    This commentary describes 2 cases from my clinic and our experience managing hepatic, neurologic, and hematologic adverse events in patients treated for melanoma with immune checkpoint inhibitors.
    Date Posted: 10/27/2016
  • 1
  • 2
  • 3
  • 4
  • 5

Latest Content

10 of 292 Shown
10 of 292 Shown
Show 10 More
Loading...